These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 803668)

  • 1. Induced prolactin release in women under long-term medroxyprogesterone acetate treatment.
    Perez-Lopez FR; Roncero MC
    Obstet Gynecol; 1975 Mar; 45(3):263-6. PubMed ID: 803668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
    Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
    Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
    Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of basal and stimulated serum levels of prolactin, growth hormone and gonadotropins in females with chronic uremia].
    Rudolf K; Rudolf H; Rüting M; Falkenhagen D
    Z Gesamte Inn Med; 1988 Oct; 43(19):542-4. PubMed ID: 3145648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
    Mishell DR
    J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
    Kotarski J; Jakowicki J
    Ginekol Pol; 1985 Oct; 56(10):581-4. PubMed ID: 2936657
    [No Abstract]   [Full Text] [Related]  

  • 9. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R; Reinilä M; Kivinén S
    Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thyrotropin releasing hormone (TRH) on the menstrual cycle in women.
    Zarate A; Schally AV; Soria J; Jacobs LS; Canales ES
    Obstet Gynecol; 1974 Apr; 43(4):487-9. PubMed ID: 4206099
    [No Abstract]   [Full Text] [Related]  

  • 11. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release.
    March CM; Marrs RP; Goebelsmann U; Mishell DR
    Obstet Gynecol; 1981 Jul; 58(1):10-6. PubMed ID: 6787487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results.
    Sala G; Castegnaro E; Lenaz GR; Martoni A; Piana E; Pannuti F
    IRCS J Med Sci; 1978 Apr; 6(4):129. PubMed ID: 12312055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsatile plasma profiles of FSH and LH before and during medroxyprogesterone acetate treatment in the bitch.
    Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Duchateau L; Kooistra HS
    Theriogenology; 2008 Jul; 70(2):179-85. PubMed ID: 18455225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.
    Jeppsson S; Johansson
    Contraception; 1976 Oct; 14(4):461-69. PubMed ID: 975831
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long-term treatment with sodium valproate on gonadotrophin and prolactin secretion in paediatric patients.
    Masala A; Meloni T; Alagna S; Rovasio PP; Rassu S; Mele G; Franca V
    Br J Clin Pharmacol; 1981 Dec; 12(6):845-8. PubMed ID: 6803821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
    Schiff I; Tulchinsky D; Cramer D; Ryan KJ
    JAMA; 1980 Sep; 244(13):1443-5. PubMed ID: 6775094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.